Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ontaneda

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Continuum (Minneapolis, Minn.)|June 5, 2019
Progressive Multiple SclerosisDaniel Ontaneda
International Journal of MS Care|March 6, 2025
LETTER FROM THE GUEST EDITORDaniel Ontaneda
Neurology|May 6, 2009
Race/ethnic differences in AD survival in us Alzheimer's disease centersDaniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2016
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - CommentaryDaniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2023
Re-thinking race and geography in multiple sclerosisDaniel Ontaneda, Lilyana Amezcua
Frontiers in Neurology|February 22, 2021
Thalamic Injury and Cognition in Multiple SclerosisMoein Amin, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 2, 2019
MOG-related disorders: A new cause of imaging-negative myelitis?Gabrielle Macaron, Daniel Ontaneda
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 6, 2017
The challenges and opportunities of multiple sclerosis care in Latin AmericaDaniel Ontaneda, Jorge Correale
Current Opinion in Neurology|April 8, 2025
Re-defining progression in multiple sclerosisJeffrey Lambe, Daniel Ontaneda
Biomedicines|August 1, 2019
Diagnosis and Management of Progressive Multiple SclerosisGabrielle Macaron, Daniel Ontaneda
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Continuum (Minneapolis, Minn.)|June 5, 2019
Progressive Multiple SclerosisDaniel Ontaneda
International Journal of MS Care|March 6, 2025
LETTER FROM THE GUEST EDITORDaniel Ontaneda
Neurology|May 6, 2009
Race/ethnic differences in AD survival in us Alzheimer's disease centersDaniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2016
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - CommentaryDaniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2023
Re-thinking race and geography in multiple sclerosisDaniel Ontaneda, Lilyana Amezcua
Frontiers in Neurology|February 22, 2021
Thalamic Injury and Cognition in Multiple SclerosisMoein Amin, Daniel Ontaneda
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 2, 2019
MOG-related disorders: A new cause of imaging-negative myelitis?Gabrielle Macaron, Daniel Ontaneda
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 6, 2017
The challenges and opportunities of multiple sclerosis care in Latin AmericaDaniel Ontaneda, Jorge Correale
Current Opinion in Neurology|April 8, 2025
Re-defining progression in multiple sclerosisJeffrey Lambe, Daniel Ontaneda
Biomedicines|August 1, 2019
Diagnosis and Management of Progressive Multiple SclerosisGabrielle Macaron, Daniel Ontaneda
Pageof 20